Rapid antibody test
The rapid antibody test (Bioeasy COVID-19 Coronavirus IgG / IgM GICA Rapid Test Kit ©) used for evaluation gives a qualitative IgG / IgM result to reveal a current or past SARS-CoV-2 infection (20). This test has been approved by the Ministry of Health for use in detecting antibody formation in risk groups in the community, healthcare workers and recovered patients. There are rapid antibody tests used for COVID-19 and produced by different companies. In head-to-head studies conducted with these tests, Bioeasy kits have been reported to have 91-95% sensitivity levels (ĸ: 0.8, p <0.001) (20). The rapid antibody test gives results in as little as 30 minutes. The serum sample taken for the test is dropped onto the cassette of the rapid test kit and the presence of antibody is qualitatively shown in 15 minutes.